Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: Reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections

British Journal of Haematology

Volumn 134, Issue 5, 2006, Pages 510-516

  Renella, Raffaele ^a   Picard, Capucine ^a,b   Neven, Bénédicte ^a   Ouachée Chardin, Marie ^a   Casanova, Jean Laurent ^a   Le Deist, Françoise ^b   Cavazzana Calvo, Marina ^b   Blanche, Stéphane ^a   Fischer, Alain ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Graft versus host disease; Haematopoietic stem cell transplantation; MHC class II deficiency; Viral infection

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADENOVIRUS; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; ENTEROVIRUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS; HLA TYPING; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II IMMUNODEFICIENCY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ACUTE DISEASE; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; MALE; METHOTREXATE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, ISOGENEIC; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 33746496632     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06213.x     Document Type: Article

References (19)

1. Antoine, C., Muller, S., Cant, A., Cavazzana-Calvo, M., Veys, P., Vossen, J., Fasth, A., Heilmann, C., Wulffraat, N., Seger, R., Blanche, S., Friedrich, W., Abinun, M., Davies, G., Bredius, R., Schulz, A., Landais, P. & Fischer, A. (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. The Lancet, 361, 553-560.
2. Beelen, D.W., Haralambie, F., Brandt, H., Linzenmeier, G., Muller, K.D., Quabeck, K., Sayer, H.G., Graeven, U., Mahmoud, H.K. & Schaefer, U.W. (1992) Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood, 80, 2668-2676.
3. Bonduel, M., Pozo, A., Zelazko, M., Raslawski, E., Delfino, S., Rossi, J., Figueroa, C. & Sackmann Muriel, F. (1999) Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency. Bone Marrow Transplantation, 24, 437-440.
4. Broers, A.E., van Der Holt, R., van Esser, J.W., Gratama, J.W., Henzen-Logmans, S., Kuenen-Boumeester, V., Lowenberg, B. & Cornelissen, J.J. (2000) Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood, 95, 2240-2245.
5. Ferrara, J.L. & Deeg, H.J. (1991) Graft-versus-host disease. New England Journal of Medicine, 324, 667-674.
6. Ferrara, J.L. & Yanik, G. (2005) Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies. Clinical Advances in Hematology & Oncology, 3, 415-419.428.
7. Fischer, A., Landais, P., Friedrich, W., Gerritsen, B., Fasth, A., Porta, F., Vellodi, A., Benkerrou, M., Jais, J.P., Cavazzana-Calvo, M., Souillet, G., Bordigoni, P., Morgan, G., Vandijken, P., Vossen, J., Locatelli, F. & Dibartolomeo, P. (1994) Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood, 83, 1149-1154.
8. Godthelp, B.C., van Eggermond, M.C., Peijnenburg, A., Tezcan, I., van Lierde, S., van Tol, M.J., Vossen, J.M. & den Elsen, P.J. (1999) Incomplete T-cell immune reconstitution in two major histocompatibility complex class Il-deficiency/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation. Blood, 94, 348-358.
9. Hill, G.R. & Ferrara, J.L. (2000) The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood, 95, 2754-2759.
10. Holler, E. (2002) Cytokines, viruses, and graft-versus-host disease. Current Opinion in Hematology, 9, 479-484.
11. Klein, C., Cavazzana-Calvo, M., Le Deist, F., Jabado, N., Benkerrou, M., Blanche, S., Lisowska-Grospierre, B., Griscelli, C. & Fischer, A. (1995) Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients. Blood, 85, 580-587.
12. Matheux, F., Ikinciogullari, A., Zapata, D.A., Barras, E., Zufferey, M., Dogu, F., Regueiro, J.R., Reith, W. & Villard, J. (2002) Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. Molecular Therapy, 6, 824-829.
13. Muta, T., Kamo, M., Gondo, H., Kato, K., Eto, T., Shibuya, T., Fukuda, T., Miyamoto, T., Nagafuji, K., Ichinohe, T. & Harada, M. (2005) Human herpesvirus-6 encephalitis followed by severe acute GVHD after a stem cell transplant from a microchimeric non-inherited maternal antigen (NIMA)-mismatched sibling. Bone Marrow Transplantation, 35, 411-413.
14. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation, 15, 825-828.
15. Rocha, V., Wagner, J.E. Jr.,, Sobocinski, K.A., Klein, J.P., Zhang, M.J., Horowitz, M.M. & Gluckman, E. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. New England Journal of Medicine, 342, 1846-1854.
16. Saleem, M.A., Arkwright, P.D., Davies, E.G., Cant, A.J. & Veys, P.A. (2000) Clinical course of patients with major histocompatibility complex class II deficiency. Archives of Disease in Childhood, 83, 356-359.
17. Villard, J., Masternak, K., Lisowska-Grospierre, B., Fischer, A. & Reith, W. (2001) MHC class II deficiency: a disease of gene regulation. Medicine, 80, 405-418.
18. Wiszniewski, W., Fondaneche, M.C., Lambert, N., Masternak, K., Picard, C., Notarangelo, L., Schwartz, K., Bal, J., Reith, W., Alcaide, C., de Saint Basile, G., Fischer, A. & Lisowska-Grospierre, B. (2000) Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics, 51, 261-267.
19. Wiszniewski, W., Fondaneche, M.C., Louise-Plence, P., Prochnicka-Chalufour, A., Selz, F., Picard, C., Le Deist, F., Eliaou, J.F., Fischer, A. & Lisowska-Grospierre, B. (2003) Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II. Immunogenetics, 54, 747-755.